Pandion Therapeutics

$11.31
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.20 (+1.80%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell PAND and other stocks, options, and ETFs commission-free!

About PAND

Pandion Therapeutics Inc. Common Stock, also called Pandion Therapeutics, is clinical stage biopharmaceutical company developing novel therapeutics designed to address the unmet needs of patients suffering from autoimmune diseases. Read More The firm develops Therapeutic Autoimmune reguLatOry protein (TALON) drug design and discovery platform. TALON platform employ a modular approach to create a pipeline of product candidates using immunomodulatory effector modules that act at known control nodes within the immune network. The company was founded on December 31, 2018 and is headquartered in Watertown, MA. The listed name for PAND is Pandion Therapeutics Inc. Common Stock.

Employees
37
Headquarters
Watertown, Massachusetts
Founded
2018
Market Cap
333.87M
Price-Earnings Ratio
Dividend Yield
Average Volume
131.49K
High Today
$11.41
Low Today
$10.96
Open Price
$11.20
Volume
24.13K
52 Week High
$27.75
52 Week Low
$10.52

Collections

PAND Earnings

-$10.15
-$6.77
-$3.38
$0.00
Q2 2020
Q3 2020
Q4 2020
Estimated
per share
Actual
Expected Feb 14, Pre-Market

You May Also Like